These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

707 related articles for article (PubMed ID: 29594035)

  • 1. Targeting Macrophages in Cancer: From Bench to Bedside.
    Poh AR; Ernst M
    Front Oncol; 2018; 8():49. PubMed ID: 29594035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Macrophages in Cancer Development and Therapy.
    Cendrowicz E; Sas Z; Bremer E; Rygiel TP
    Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33919517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cross-talk between macrophages and tumor cells as a target for cancer treatment.
    Aizaz M; Khan A; Khan F; Khan M; Musad Saleh EA; Nisar M; Baran N
    Front Oncol; 2023; 13():1259034. PubMed ID: 38033495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophages as a Potential Immunotherapeutic Target in Solid Cancers.
    Mishra AK; Banday S; Bharadwaj R; Ali A; Rashid R; Kulshreshtha A; Malonia SK
    Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Tumor-Associated Macrophages in Sarcomas.
    Fujiwara T; Healey J; Ogura K; Yoshida A; Kondo H; Hata T; Kure M; Tazawa H; Nakata E; Kunisada T; Fujiwara T; Ozaki T
    Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33802565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophages at the crossroads of anticancer strategies.
    Cortese N; Donadon M; Rigamonti A; Marchesi F
    Front Biosci (Landmark Ed); 2019 Jun; 24(7):1271-1283. PubMed ID: 31136979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of tumor-associated macrophage in breast cancer biology.
    Choi J; Gyamfi J; Jang H; Koo JS
    Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing tumor-associated macrophages as aids for cancer immunotherapy.
    Li X; Liu R; Su X; Pan Y; Han X; Shao C; Shi Y
    Mol Cancer; 2019 Dec; 18(1):177. PubMed ID: 31805946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated macrophages in breast cancer: Innocent bystander or important player?
    Qiu SQ; Waaijer SJH; Zwager MC; de Vries EGE; van der Vegt B; Schröder CP
    Cancer Treat Rev; 2018 Nov; 70():178-189. PubMed ID: 30227299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in Tumor-Associated Macrophages: From Bench to Bedside.
    Wang Y; Lin YX; Qiao SL; Wang J; Wang H
    Adv Biosyst; 2019 Feb; 3(2):e1800232. PubMed ID: 32627370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophages in the microenvironment of head and neck cancer: potential targets for cancer therapy.
    Evrard D; Szturz P; Tijeras-Raballand A; Astorgues-Xerri L; Abitbol C; Paradis V; Raymond E; Albert S; Barry B; Faivre S
    Oral Oncol; 2019 Jan; 88():29-38. PubMed ID: 30616794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour-associated macrophages as treatment targets in oncology.
    Mantovani A; Marchesi F; Malesci A; Laghi L; Allavena P
    Nat Rev Clin Oncol; 2017 Jul; 14(7):399-416. PubMed ID: 28117416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-associated macrophages: an accomplice in solid tumor progression.
    Chen Y; Song Y; Du W; Gong L; Chang H; Zou Z
    J Biomed Sci; 2019 Oct; 26(1):78. PubMed ID: 31629410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-associated macrophages: from basic research to clinical application.
    Yang L; Zhang Y
    J Hematol Oncol; 2017 Feb; 10(1):58. PubMed ID: 28241846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage Polarization: Anti-Cancer Strategies to Target Tumor-Associated Macrophage in Breast Cancer.
    Tariq M; Zhang J; Liang G; Ding L; He Q; Yang B
    J Cell Biochem; 2017 Sep; 118(9):2484-2501. PubMed ID: 28106295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-Associated Macrophages as Target for Antitumor Therapy.
    Sawa-Wejksza K; Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):97-111. PubMed ID: 28660349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. M1 Macrophage-Derived Nanovesicles Potentiate the Anticancer Efficacy of Immune Checkpoint Inhibitors.
    Choo YW; Kang M; Kim HY; Han J; Kang S; Lee JR; Jeong GJ; Kwon SP; Song SY; Go S; Jung M; Hong J; Kim BS
    ACS Nano; 2018 Sep; 12(9):8977-8993. PubMed ID: 30133260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting tumor-associated macrophages in the tumor microenvironment.
    Zhou K; Cheng T; Zhan J; Peng X; Zhang Y; Wen J; Chen X; Ying M
    Oncol Lett; 2020 Nov; 20(5):234. PubMed ID: 32968456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages.
    Qian Y; Qiao S; Dai Y; Xu G; Dai B; Lu L; Yu X; Luo Q; Zhang Z
    ACS Nano; 2017 Sep; 11(9):9536-9549. PubMed ID: 28858473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage polarization as a novel weapon in conditioning tumor microenvironment for bladder cancer: can we turn demons into gods?
    Rubio C; Munera-Maravilla E; Lodewijk I; Suarez-Cabrera C; Karaivanova V; Ruiz-Palomares R; Paramio JM; Dueñas M
    Clin Transl Oncol; 2019 Apr; 21(4):391-403. PubMed ID: 30291519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.